EMILY SCHLINZ: Open Payments
NPI 1205345139 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 28 payments from 12 companies in 2025. Trend: 2023 $355 · 2024 $600 · 2025 $697
Food & beverage: $597Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $244 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| GENZYME CORPORATION | 2 | $74 |
| UCB, Inc. | 2 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| LEO Pharma Inc. | 2 | $43 |
| Almirall LLC | 2 | $43 |
| Organon LLC | 2 | $38 |
| ABBVIE INC. | 1 | $25 |
| Botanix SB Inc | 1 | $21 |
Products named: TREMFYA, LIBTAYO, DUPIXENT, Bimzelx, Zoryve, VTAMA, Seysara, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
